Literature DB >> 33153675

Overview of Atypical Diabetes.

Jaclyn Tamaroff1, Marissa Kilberg2, Sara E Pinney2, Shana McCormack2.   

Abstract

Although type 1 diabetes mellitus and, to a lesser extent, type 2 diabetes mellitus, are the prevailing forms of diabetes in youth, atypical forms of diabetes are not uncommon and may require etiology-specific therapies. By some estimates, up to 6.5% of children with diabetes have monogenic forms. Mitochondrial diabetes and cystic fibrosis related diabetes are less common but often noted in the underlying disease. Atypical diabetes should be considered in patients with a known disorder associated with diabetes, aged less than 25 years with nonautoimmune diabetes and without typical characteristics of type 2 diabetes mellitus, and/or with comorbidities associated with atypical diabetes.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atypical diabetes; Cystic fibrosis–related diabetes (CFRD); Maturity-onset diabetes of the young (MODY); Mitochondrial diabetes; Monogenic diabetes; Neonatal diabetes

Year:  2020        PMID: 33153675      PMCID: PMC8221417          DOI: 10.1016/j.ecl.2020.07.004

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  166 in total

1.  Morbidity and mortality in the Wolfram syndrome.

Authors:  B T Kinsley; M Swift; R H Dumont; R G Swift
Journal:  Diabetes Care       Date:  1995-12       Impact factor: 19.112

2.  Cortical excitability changes correlate with fluctuations in glucose levels in patients with epilepsy.

Authors:  Radwa A B Badawy; Simon J Vogrin; Alan Lai; Mark J Cook
Journal:  Epilepsy Behav       Date:  2013-04-18       Impact factor: 2.937

3.  Islet Hormone and Incretin Secretion in Cystic Fibrosis after Four Months of Ivacaftor Therapy.

Authors:  Andrea Kelly; Diva D De Leon; Saba Sheikh; Devaney Camburn; Christina Kubrak; Amy J Peleckis; Darko Stefanovski; Denis Hadjiliadis; Michael R Rickels; Ronald C Rubenstein
Journal:  Am J Respir Crit Care Med       Date:  2019-02-01       Impact factor: 21.405

Review 4.  A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data.

Authors:  Evgenia Gourgari; Erin E Wilhelm; Hamid Hassanzadeh; Vanita R Aroda; Ira Shoulson
Journal:  J Diabetes Complications       Date:  2017-08-12       Impact factor: 2.852

Review 5.  A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect.

Authors:  Michael P Boyle; Kris De Boeck
Journal:  Lancet Respir Med       Date:  2013-01-30       Impact factor: 30.700

6.  Rare autosomal dominant POLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease.

Authors:  Sarah E Hopkins; Arthur Somoza; Donald L Gilbert
Journal:  J Child Neurol       Date:  2009-10-08       Impact factor: 1.987

7.  Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood.

Authors:  Sarah E Flanagan; Ann-Marie Patch; Deborah J G Mackay; Emma L Edghill; Anna L Gloyn; David Robinson; Julian P H Shield; Karen Temple; Sian Ellard; Andrew T Hattersley
Journal:  Diabetes       Date:  2007-04-19       Impact factor: 9.461

Review 8.  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020.

Authors: 
Journal:  Diabetes Care       Date:  2020-01       Impact factor: 19.112

9.  Familial myopathy: new insights into the T14709C mitochondrial tRNA mutation.

Authors:  Robert McFarland; Andrew M Schaefer; Julie L Gardner; Stephen Lynn; Christine M Hayes; Martin J Barron; Mark Walker; Patrick F Chinnery; Robert W Taylor; Douglass M Turnbull
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

10.  Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics.

Authors:  Robert D S Pitceathly; Conrad Smith; Carl Fratter; Charlotte L Alston; Langping He; Kate Craig; Emma L Blakely; Julie C Evans; John Taylor; Zarfishan Shabbir; Marcus Deschauer; Ute Pohl; Mark E Roberts; Matthew C Jackson; Christopher A Halfpenny; Peter D Turnpenny; Peter W Lunt; Michael G Hanna; Andrew M Schaefer; Robert McFarland; Rita Horvath; Patrick F Chinnery; Douglass M Turnbull; Joanna Poulton; Robert W Taylor; Gráinne S Gorman
Journal:  Brain       Date:  2012-10-29       Impact factor: 13.501

View more
  1 in total

Review 1.  Genome Editing Human Pluripotent Stem Cells to Model β-Cell Disease and Unmask Novel Genetic Modifiers.

Authors:  Matthew N George; Karla F Leavens; Paul Gadue
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-02       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.